The Adherence to Oral Anticoagulant in Chinese Patients With NVAF (NVAF)
Study of Compliance and Influencing Factors in Chinese Patients With Nonvalvular Atrial Fibrillation (NVAF) to Oral Anticoagulant
연구 개요
상태
상태
정황
정황
개입 / 치료
개입 / 치료
상세 설명
- The general information about these patients was recorded such as gender, age, smoking history, drinking history, heart failure, hypertension, diabetes, coronary heart disease, stroke history, TIA history, peripheral vascular disease, etc. CHA2DS2-VASc score and HAS-BLED score were recorded.
- Medication information and follow-up information was collected.For the patients included in the study, the medication records of oral anticoagulants (outpatient, emergency, hospitalization), adverse reactions, anticoagulant use history, drug withdrawal or dressing change, disease changes, etc. within three years were recorded by referring to the patient's medical records.
연구 유형
연구 유형
등록 (예상)
등록
연락처 및 위치
연구 연락처
연구 연락처
- 이름: chang cuie, master
- 전화번호: 15990165032
- 이메일: changcuie123@163.com
연구 연락처 백업
- 이름: zhang xiaoyu, master
- 전화번호: 18858160685
- 이메일: 474430517@qq.com
연구 장소
-
-
Zhejiang
-
Hangzhou, Zhejiang, 중국, 086
- Chang Cuie
-
연락하다:
- chang cuie, master
- 전화번호: 086-15990165032
- 이메일: changcuie123@163.com
-
연락하다:
- zhang xiaoyu, master
- 전화번호: 086-18858160685
- 이메일: 474430517@qq.com
-
수석 연구원:
- huang yuwen, master
-
-
참여기준
자격 기준
자격 기준
공부할 수 있는 나이
- 어린이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
설명
Inclusion Criteria:
NVAF; CHA2DS2-VASc≥2(femal≥3); After starting the medication, the duration of continuous medication was more than 3 months
Exclusion Criteria:
The patients had the records of anticoagulants in other hospitals; Patients lost to follow-up; Patients who do not need long-term anticoagulants after successful radiofrequency ablation or left atrial appendage occlusion. The follow-up time was 3 years or the following conditions occurred: the patient's condition changed and no longer used oral anticoagulants or died, the follow-up was stopped.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
그룹/코호트 수
코호트 및 개입
그룹/코호트그룹/코호트 |
개입 / 치료개입 / 치료 |
|---|---|
|
dabigatran group
NVAF patients who taking dabigatran capsule 110mg,bid during 2016.2-2021.1,the
duration of continuous medication was more than 3 months.PDC value and MMAS-8 scale were used to evaluate the compliance of patients with dabigatran.
|
PDC value and MMAS-8 scale were used to evaluate the compliance of patients with dabigatran, rivaroxaban and wafarin
|
|
Rivaroxaban group
NVAF patients who taking rivaroxaban tablet 15mg,bid during 2016.2-2021.1,the
duration of continuous medication was more than 3 months.PDC value and mmas-8 scale were used to evaluate the compliance of patients with dabigatran.
PDC value and mmas-8 scale were used to evaluate the compliance of patients with rivaroxaban.
|
PDC value and MMAS-8 scale were used to evaluate the compliance of patients with dabigatran, rivaroxaban and wafarin
|
|
wafarin group
NVAF patients who taking wafarin tablet during 2016.2-2021.1,the
duration of continuous medication was more than 3 months, the dosage is adjusted according to INR.
MMAS-8 scale was used to evaluate the compliance of patients with rivaroxaban.evaluate
the compliance of patients with wafarin.
|
PDC value and MMAS-8 scale were used to evaluate the compliance of patients with dabigatran, rivaroxaban and wafarin
|
연구는 무엇을 측정합니까?
주요 결과 측정
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
The long-term compliance of oral anticoagulants in NVAF patients was compared among warfarin group, dabigatran group and rivaroxaban group.
기간: 6 months
|
In this study, the eight item Morisky medication adherence scale (MMAS-8) was used to compare the long-term compliance of patients with warfarin, dabigatran axetil and rivaroxaban.
The proportion of days covered (PDC) was used to compare the long-term compliance of patients with dabigatran and rivaroxaban.
|
6 months
|
2차 결과 측정
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Explore the influence of different factors on patients' compliance, and to find out the factors influencing patients' long-term compliance, so as to provide basis for formulating strategies to improve patients' long-term compliance.
기간: 6 months
|
Data of all influencing factors included in CHA2DS2-VASc score scale, such as age hypertension,heart failure, diabetes, women and vascular diseases, as well as region, medical insurance category, education level, anticoagulant use history and HAS-BLED score
|
6 months
|
|
Through multivariate logistic regression analysis, to clarify the impact of various factors on long-term compliance of patients.
기간: 6 months
|
Univariate analysis of significant variables, further by multivariate logistic regression analysis
|
6 months
|
공동 작업자 및 조사자
스폰서
스폰서
수사관
수사관
- 수석 연구원: huang yuwen, master, The Second Affiliated Hospital of Medical College of Zhejiang University
연구 기록 날짜
연구 주요 날짜
연구 시작 (예상)
연구 시작
기본 완료 (예상)
기본 완료
연구 완료 (예상)
연구 완료
연구 등록 날짜
최초 제출
최초 제출
QC 기준을 충족하는 최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
처음 게시됨
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
마지막 업데이트 게시됨
QC 기준을 충족하는 마지막 업데이트 제출
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
기타 연구 ID 번호
- 2020-966
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .